Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes.

PubWeight™: 1.30‹?› | Rank: Top 10%

🔗 View Article (PMID 16298335)

Published in Biochem Biophys Res Commun on November 15, 2005

Authors

Nora Klöting1, Janin Berndt, Susan Kralisch, Peter Kovacs, Mathias Fasshauer, Michael R Schön, Michael Stumvoll, Matthias Blüher

Author Affiliations

1: University of Leipzig, Department of Internal Medicine III, 04103 Leipzig, Germany.

Articles citing this

Adipokines and insulin resistance. Mol Med (2008) 2.97

Mechanisms and metabolic implications of regional differences among fat depots. Cell Metab (2013) 1.94

Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm (2010) 1.80

Release of inflammatory mediators by human adipose tissue is enhanced in obesity and primarily by the nonfat cells: a review. Mediators Inflamm (2010) 1.65

What's new in our understanding of the role of adipokines in rheumatic diseases? Nat Rev Rheumatol (2011) 1.63

(n-3) Fatty acids alleviate adipose tissue inflammation and insulin resistance: mechanistic insights. Adv Nutr (2011) 1.39

New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med Genet (2011) 1.24

Vascular biology of metabolic syndrome. J Vasc Surg (2011) 1.21

Sex dimorphism and depot differences in adipose tissue function. Biochim Biophys Acta (2013) 1.10

Clinical relevance of adipokines. Diabetes Metab J (2012) 1.10

Potential role of leptin, adiponectin and three novel adipokines--visfatin, chemerin and vaspin--in chronic hepatitis. Mol Med (2011) 0.95

Identification of adipokine clusters related to parameters of fat mass, insulin sensitivity and inflammation. PLoS One (2014) 0.94

Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns. Arch Med Sci (2015) 0.93

Effects of bariatric surgery on adipokine-induced inflammation and insulin resistance. Front Endocrinol (Lausanne) (2013) 0.90

Regulation of visceral adipose tissue-derived serine protease inhibitor by nutritional status, metformin, gender and pituitary factors in rat white adipose tissue. J Physiol (2009) 0.90

Association between novel adipocytokines adiponectin, vaspin, visfatin, and thyroid: An experimental and clinical update. Endocr Connect (2013) 0.86

Vaspin inhibits kallikrein 7 by serpin mechanism. Cell Mol Life Sci (2013) 0.84

The role of vaspin in the development of metabolic and glucose tolerance disorders and atherosclerosis. Biomed Res Int (2015) 0.84

Novel common and rare genetic determinants of paraoxonase activity: FTO, SERPINA12, and ITGAL. J Lipid Res (2012) 0.83

Role of serum vaspin in progression of type 2 diabetes: a 2-year cohort study. PLoS One (2014) 0.83

[Adipokine update - new molecules, new functions]. Wien Med Wochenschr (2010) 0.81

Combined effects of body mass index and cardio/respiratory fitness on serum vaspin concentrations in Korean young men. Eur J Appl Physiol (2009) 0.81

Associations between tissue visfatin/nicotinamide, phosphoribosyltransferase (Nampt), retinol binding protein-4, and vaspin concentrations and insulin resistance in morbidly obese subjects. Mediators Inflamm (2013) 0.81

Effects of 8 weeks resistance training on plasma vaspin and lipid profile levels in adult men with type 2 diabetes. Caspian J Intern Med (2014) 0.80

Adipokines as potential biomarkers in rheumatoid arthritis. Mediators Inflamm (2014) 0.78

Assessment of serum chemerin, vaspin and omentin-1 levels in patients with polycystic ovary syndrome. J Int Med Res (2016) 0.78

Vaspin promotes 3T3-L1 preadipocyte differentiation. Exp Biol Med (Maywood) (2015) 0.77

Association of serum vaspin and adiponectin levels with renal function in patients with or without type 2 diabetes mellitus. J Diabetes Res (2014) 0.77

Mediatory effect of circulating vaspin on resting metabolic rate in obese individuals. Eur J Nutr (2015) 0.76

Recently discovered adipokines and cardio-metabolic comorbidities in childhood obesity. Int J Mol Sci (2014) 0.76

Effect of statin therapy on vaspin levels in type 2 diabetic patients. Clin Pharmacol (2013) 0.76

Resveratrol attenuates visfatin and vaspin genes expression in adipose tissue of rats with type 2 diabetes. Iran J Basic Med Sci (2015) 0.75

Impact of age on plasma vaspin concentration in a group of normal Chinese people. J Endocrinol Invest (2016) 0.75

Increased vaspin levels are associated with beneficial metabolic outcome pre- and post-bariatric surgery. PLoS One (2014) 0.75

Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis. World J Gastroenterol (2017) 0.75

[Adipokines in healthy and obese children]. An Pediatr (Barc) (2012) 0.75

Low vaspin levels are related to endothelial dysfunction in patients with ankylosing spondylitis. Braz J Med Biol Res (2016) 0.75

Is vaspin related to cardio-metabolic status and autonomic function in early stages of glucose intolerance and in metabolic syndrome? Diabetol Metab Syndr (2016) 0.75

Expression of vaspin in the joint and the levels in the serum and synovial fluid of patients with osteoarthritis. Int J Clin Exp Med (2014) 0.75

The effect of physical activity on serum IL-6 and vaspin levels in late elementary school children. J Exerc Nutrition Biochem (2015) 0.75

Genetic Determination of Serum Levels of Diabetes-Associated Adipokines. Rev Diabet Stud (2016) 0.75

Articles by these authors

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08

Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Variation in FTO contributes to childhood obesity and severe adult obesity. Nat Genet (2007) 13.62

Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med (2008) 12.41

Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med (2006) 9.53

Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94

Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66

Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet (2010) 6.49

Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nat Genet (2009) 6.39

New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58

T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol (2008) 5.44

Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci U S A (2009) 5.19

Acute cholecystitis: early versus delayed cholecystectomy, a multicenter randomized trial (ACDC study, NCT00447304). Ann Surg (2013) 5.12

Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5. Nature (2010) 5.01

Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc Natl Acad Sci U S A (2006) 4.81

Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet (2012) 4.73

A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet (2012) 4.37

Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07

68Ga-DOTA-Tyr3-octreotide PET in neuroendocrine tumors: comparison with somatostatin receptor scintigraphy and CT. J Nucl Med (2007) 3.98

Effects of Initiating Moderate Alcohol Intake on Cardiometabolic Risk in Adults With Type 2 Diabetes: A 2-Year Randomized, Controlled Trial. Ann Intern Med (2015) 3.78

Insulin-sensitive obesity. Am J Physiol Endocrinol Metab (2010) 3.46

A novel ChREBP isoform in adipose tissue regulates systemic glucose metabolism. Nature (2012) 3.35

Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25

Common nonsynonymous variants in PCSK1 confer risk of obesity. Nat Genet (2008) 3.24

Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21

Two new Loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and german study groups. PLoS Genet (2010) 3.21

New gene functions in megakaryopoiesis and platelet formation. Nature (2011) 3.14

Retracted Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling. J Biol Chem (2003) 3.06

Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04

Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet (2013) 2.83

Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity. J Clin Endocrinol Metab (2007) 2.81

Seventy-five genetic loci influencing the human red blood cell. Nature (2012) 2.77

FTO genotype is associated with phenotypic variability of body mass index. Nature (2012) 2.77

Lead poisoning due to adulterated marijuana in leipzig. Dtsch Arztebl Int (2008) 2.72

Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes (2003) 2.71

CUBN is a gene locus for albuminuria. J Am Soc Nephrol (2011) 2.70

Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab (2007) 2.69

Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis. Nat Genet (2007) 2.48

Detailed physiologic characterization reveals diverse mechanisms for novel genetic Loci regulating glucose and insulin metabolism in humans. Diabetes (2010) 2.44

Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes (2006) 2.40

Recommendations for laparoscopic liver resection: a report from the second international consensus conference held in Morioka. Ann Surg (2015) 2.36

Plasma visfatin concentrations and fat depot-specific mRNA expression in humans. Diabetes (2005) 2.34

Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance. Diabetologia (2015) 2.25

Variants in CPA1 are strongly associated with early onset chronic pancreatitis. Nat Genet (2013) 2.10

Total and high-molecular weight adiponectin in relation to metabolic variables at baseline and in response to an exercise treatment program: comparative evaluation of three assays. Diabetes Care (2007) 2.04

Serum levels of the adipokine progranulin depend on renal function. Diabetes Care (2012) 2.03

Genome-wide association and genetic functional studies identify autism susceptibility candidate 2 gene (AUTS2) in the regulation of alcohol consumption. Proc Natl Acad Sci U S A (2011) 2.01

Autocrine IGF-1 action in adipocytes controls systemic IGF-1 concentrations and growth. Diabetes (2008) 1.97

Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes (2007) 1.96